Nonreplacement therapy for hemophilia in low-income countries: experience from a prospective study in Ivory Coast

Catherine Lambert,N'Dogomo Meité, Gustave Koffi Kouassi,Alexis Silué Dohoma,Sara Adélaide Bognini Akou,Ibrahima Sanogo,Cedric Hermans

Research and Practice in Thrombosis and Haemostasis（2023）

引用 2|浏览10

暂无评分

摘要

•New hemophilia treatment options are currently mainly available in high-income countries.•A majority of people with hemophilia worldwide still have no access to appropriate care.•We studied how access to emicizumab modified the burden of hemophilia in boys from Ivory Coast.•The impact of innovative hemophilia therapies is magnified in low-income countries.

查看译文

关键词

emicizumab,hemophilia A,innovative therapies,Ivory Coast,low-income countries

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要